The BBC has spoken to passengers, transport staff and bus drivers about a growing national trend of antisocial behaviour on public transport. Continue Reading »
Corona Remedies' IPO saw a remarkable 144.4 times subscription rate, driven by high institutional demand. The issue, priced between ₹1008-1062, is expected to list on December 15, with a grey market premium indicating a listing price of ₹1,332 per share. Continue Reading »
Wakefit's IPO, launched on December 10, was oversubscribed 2.52 times, driven by strong retail interest. The company reported ₹724 crore in revenue and ₹35.5 crore profit for the six months ending September 2025, with promoter shareholding set to drop to 37%. Continue Reading »
US Fed Meeting 2025 LIVE: US Federal Reserve Chairman Jerome Powell-led FOMC is set to announce the outcome of its two-day meeting on Wednesday, 10 December 2025. Markets are predicting a 25 basis point rate cut ahead amid elevated inflation. Continue Reading »
Aequs, specializing in aerospace parts, had a successful IPO, listing at ₹140, a 13% increase from its price. Experts recommend a balanced investment strategy, advising profit booking and holding shares for potential long-term growth. Continue Reading »
Expert view on markets: As India gears up for 2026, PL Capital's research director shares bullish insights on the stock market, emphasising key sectors poised for growth, including consumption and BFSI. Continue Reading »
Flywings Simulator Training Centre IPO allotment date is fixed as Wednesday, December 10. The offer allotment is generally finalised a day after the closure of the issue. The ₹57.05 crore IPO was open for bidding from December 5 to December 9, garnering 1.67 times bids. Continue Reading »
Major indices on Dalal Street continued to decline, marking three consecutive days of losses as investors reacted cautiously ahead of the US Federal Reserve's decision. The Nifty 50 and Sensex fell, with mid- and small-cap stocks also affected, indicating a challenging market environment. Continue Reading »